Many lung cancer patients now have access to a potentially life-saving medication. Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a certain genetic mutation and have had surgery to remove cancerous tumors. Among those patients, Tagrisso was shown to reduce …
Read More »Lung cancer pill shows 'earth-shattering' results in 5-year study: 'An optimistic time'
